Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221 CHF | +1.01% | -0.50% | -9.61% |
04-26 | Roche: positive CHMP opinion for Alecensa | CF |
04-26 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.61% | 195B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-6.26% | 145B | |
-11.77% | 144B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche : To Disclose Updated Results On 19 Approved, Investigational Therapies For Cancers